Individualized Neurodevelopmental Treatment

This study has been completed.
Sponsor:
Information provided by:
Hellenic Society for Disabled Children
ClinicalTrials.gov Identifier:
NCT00922077
First received: June 1, 2009
Last updated: June 16, 2009
Last verified: June 2009

June 1, 2009
June 16, 2009
January 2008
April 2008   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00922077 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Individualized Neurodevelopmental Treatment
Individualized Neurodevelopmental Treatment

The purpose of the study was to evaluate this therapeutic intervention by expressing functional level with valid quantitative data.

The intervention lasted 6 weeks. There were 3 sessions per week. At each session there was a part of standard physical therapy program and there was also a part with emphasis on dynamic balance exercises.

Interventional
Phase 3
Intervention Model: Single Group Assignment
Primary Purpose: Treatment
Cerebral Palsy
Behavioral: standard physical therapy program with emphasis on dynamic balance exercises
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1
April 2008
April 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • spastic tetraplegia

Exclusion Criteria:

  • vision problems
Female
6 Years to 9 Years
Not Provided
Contact information is only displayed when the study is recruiting subjects
Greece
 
NCT00922077
001-Nikodelis
Yes
Gait Laboratory ELEPAP THESSALONIKI
Hellenic Society for Disabled Children
Not Provided
Not Provided
Hellenic Society for Disabled Children
June 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP